信息發展(300469.SZ):國盛海通基金已減持207.33萬股 因誤操作多減持2.2萬股
格隆匯 9 月 17日丨信息發展(300469.SZ)公佈,公司於近日收到國盛海通基金出具的《持股5%以上股東減持股份計劃時間過半告知函》。其減持股份計劃時間已經過半,減持股數207.33萬股,減持比例1.0107%。
國盛海通基金於2020年8月31日至2020年9月9日期間通過集中競價方式減持公司股份207.33萬股,已達到公司總股本的1.0107%,因誤操作多減持2.2萬股。此次減持違反了《深圳證券交易所上市公司股東及董事、監事、高級管理人員減持股份實施細則》的相關規定,同時違反了減持計劃中的相關承諾。後續國盛海通基金將嚴格規範股票減持行為,杜絕上述問題的再次發生。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.